Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
37 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
131.5 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
SCE DEP DE L EDUCATION NATIONALE
INSPECTION ACADEMIQUE SCE DEP DE L EDUCATION NATIONALE 7 RUE DUPANLOUP, 74000 ANNECY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
International journal of clinical oncology · 2023
BMC surgery · 2023
Abstract Aims A variety of factors have been reported to affect long-term outcomes after radical resection of hepatocellular carcinoma (HCC). However, the indicators remain controversial. The purpose of this study was to evaluate the relationship between myosteatosis of the multifidus muscle and long-term outcomes after radical surgery for HCC. Methods We retrospectively analyzed clinicopathological data for 187 patients with HCC who underwent radical surgery at Tokushima University between January 2009 and December 2020 and measured the density of fat in the multifidus muscle at L3 on their preoperative magnetic resonance images (MRI). Associations of myosteatosis and clinicopathological factors with long-term outcomes were evaluated. Results The patients were divided into a myosteatosis-negative group (n = 122) and a myosteatosis-positive group (n = 65). The cancer-specific survival rate after hepatectomy was significantly worse in the myosteatosis-positive group than in the myosteatosis-negative group (p = 0.03). Univariate analysis identified multiple tumors, stage III/IV disease, an alfa-fetoprotein level ≥ 10 ng/ml, PIVKA-II ≥ 400 AU/ml, vp(+) status, and myosteatosis to be prognostic factors for cancer-specific survival. Multivariate analysis revealed multiple tumors, an alfa-fetoprotein level ≥ 10 ng/ml, and myosteatosis to be independent prognostic factors. Conclusions Myosteatosis measured by MRI is a simple and useful predictor of the long-term outcome after radical surgery for HCC.
Hepatology research : the official journal of the Japan Society of Hepatology · 2023
AbstractAimRecent advances in treatment modalities have been made, limiting the indication of hepatic resection in the treatment strategy for hepatocellular carcinoma (HCC) patients. This retrospective study investigated the significance of multiplication of tumor maximum diameter and number (MDN) as a surgical indicator for Barcelona Clinic Liver Cancer intermediate‐stage HCC.MethodsA total of 49 patients with Barcelona Clinic Liver Cancer intermediate‐stage HCC who underwent curative hepatic resection between 2000 and 2020 were enrolled in this study. Prognostic factors of overall survival and disease‐free survival, including the product of MDN, were analyzed.ResultsPatients with MDN >12 experienced significantly worse prognosis compared with those with MDN ≤12 (p = 0.0395), and 5‐year overall survival rates after hepatic resection were 60.0% and 23.4%, respectively. Furthermore, the disease‐free survival rate of patients with MDN >12 was significantly worse compared with those with MDN ≤12 (p = 0.0049), and all patients with MDN >12 experienced recurrence within 3 years after hepatic resection. In the multivariate analysis, MDN >12 was identified as the only independent prognostic factor of both overall survival and disease‐free survival. In addition, patients with MDN >12 suffered from uncontrollable recurrence by locoregional treatment, such as more than four intrahepatic and extrahepatic recurrences, after hepatic resection.ConclusionsMDN index might be a new surgical indicator for Barcelona Clinic Liver Cancer intermediate‐stage HCC, and influence clinical decision‐making for individual treatment strategies.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
The Journal of surgical research · 2026 · Journal Article
Yamada S, Morine Y, Ikemoto T, Saito Y, et al.
The Journal of international medical research · 2026 · Journal Article
Been Sayeed SKJ, M M, Mahmud R, Rahman S, et al.
Molecular cancer · 2026 · Journal Article
Miyazaki K, Montcusí B, Morine Y, Okuno K, et al.
Hepatology (Baltimore, Md.) · 2026 · Journal Article
Yamazoe T, Kakazu E, Matsuda M, Mino M, et al.
The journal of medical investigation : JMI · 2026 · Journal Article
Tokunaga T, Kashihara H, Nakao T, Yoshimoto T, et al.
The journal of medical investigation : JMI · 2026 · Journal Article
Ogawa H, Kinouchi K, Ichimura-Shimizu M, Yawata N, et al.
Annals of surgical oncology · 2025 · Journal Article
Saito Y, Morine Y, Yamada S, Teraoku H, et al.
Hepatology research : the official journal of the Japan Society of Hepatology · 2025 · Journal Article
Ishii T, Shindoh J, Nakamura I, Hirono S, et al.
Medicine · 2025 · Journal Article
Yamada S, Morine Y, Ikemoto T, Saito Y, et al.
World journal of surgery · 2025 · Comparative Study
Kashihara H, Tokunaga T, Yoshimoto T, Wada Y, et al.
Bioinformation · 2025 · Journal Article
G N, M SSL, V S, K S, et al.
The journal of medical investigation : JMI · 2025 · Journal Article
Noma T, Wada Y, Nishi M, Teraoku H, et al.
The journal of medical investigation : JMI · 2025 · Journal Article
Yamada S, Morine Y, Ikemoto T, Saito Y, et al.
The journal of medical investigation : JMI · 2025 · Journal Article
Saito Y, Chen S, Ikemoto T, Teraoku H, et al.
Oncology letters · 2024 · Journal Article
Yamada S, Morine Y, Ikemoto T, Saito Y, et al.
The journal of medical investigation : JMI · 2024 · Journal Article
Morine Y, Saito Y, Yamada S, Hiroki T, et al.
Brain, behavior, & immunity - health · 2023 · Journal Article
Graïc JM, Finos L, Vadori V, Cozzi B, et al.
Hepatology research : the official journal of the Japan Society of Hepatology · 2023 · Journal Article
Morine Y, Saito Y, Yamada S, Teraoku H, et al.
PLoS neglected tropical diseases · 2023 · Journal Article
Guttapadu R, Prakash N, M A, Chatterjee R, et al.
Clinical rheumatology · 2025 · Journal Article
A K, M EA, M H, H A, et al.
Rheumatology and immunology research · 2024 · Journal Article
Datta D, Khatun M, Bankura B, Sarkar M, et al.
Physiotherapy · 2026 · Letter
Rashid FA, M RP
International journal of clinical oncology · 2023 · Randomized Controlled Trial
Kayashima H, Itoh S, Shimokawa M, Hayashi H, et al.
Clinical journal of gastroenterology · 2025 · Journal Article
Saito Y, Morine Y, Yamada S, Teraoku H, et al.
The journal of medical investigation : JMI · 2025 · Journal Article
Shinya T, Morine Y, Ishibashi H, Tanaka H, et al.
Cureus · 2024 · Case Reports
Surapaneni D, Dasi SC, Sam N, M J
JMIR research protocols · 2025 · Journal Article
M A, Ahmad A, A A, Raj LS, et al.
Clinical rheumatology · 2025 · Journal Article
Mohan A, Mohan A, Ramachandran A, Pulinilkunnathil JG, et al.
BMC surgery · 2023 · Journal Article
Yoshikawa K, Shimada M, Morine Y, Ikemoto T, et al.
BMJ case reports · 2025 · Journal Article
Pathrot D, Nachappa AA, Mannual S, M SK
Indian journal of dermatology, venereology and leprology · 2023 · Letter
Rao AG, M N, Ch S, Jhawar J
Radiology case reports · 2023 · Case Reports
Lee ZR, Lai YK, M L, Khor LY, et al.
Surgery today · 2023 · Journal Article
Mori H, Noma T, Morine Y, Ishibashi H, et al.
Cureus · 2025 · Journal Article
Nallaperumal S, V P, M C V, Pusapati LCV, et al.
Cureus · 2024 · Case Reports
Mohan A, Kuriakose SM, James L, G BT, et al.
JACC. Case reports · 2024 · Case Reports
Kharge JL, M UK, M L J, Newaskar AA, et al.
Cureus · 2023 · Journal Article
M D, Kumar J, Ramalingam K